NEORX CORPORATION

Company Information

Company Name
NEORX CORPORATION
Address
410 W HARRISON ST
SEATTLE, WA, 98119
Phone
1 206-281-7001
URL
n/a
DUNS
n/a
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$654,518.00
11
SBIR Phase II
$1,857,331.00
4
STTR Phase I
$100,000.00
1

Award List

  1. THE PURPOSE OF THIS PROJECT IS TO DEVELOP AND CHARACTERIZE MONOCLONAL ANTIBODIES WHICH CAN BE USED IN THE FORM OF RADIONUCLIDE IMMUNOCONJUGATES FOR IN VIVO IMAGING OF B-CELL LYMPHOMAS.

    Amount: $50,000.00

    THE PURPOSE OF THIS PROJECT IS TO DEVELOP AND CHARACTERIZE MONOCLONAL ANTIBODIES WHICH CAN BE USED IN THE FORM OF RADIONUCLIDE IMMUNOCONJUGATES FOR IN VIVO IMAGING OF B-CELL LYMPHOMAS. NO MONOCLONAL A ...

    SBIR Phase I 1985 Department of Health and Human Services
  2. RADIOIODINATED CONJUGATES FOR THERAPY AND DIAGNOSIS

    Amount: $500,000.00

    THE PURPOSE OF THIS CONTRACT PROPOSAL IS TO DEVELOP NEW RADIOIODINE-LABELED CONJUGATES FOR MONOCLONAL ANTIBODIES THAT CAN BE USED IN DIAGNOSIS AND THERAPY OF CANCER. THE GOAL OF OUR PROPOSED RESEARCH ...

    SBIR Phase II 1986 Department of Health and Human Services
  3. RADIORHENIUM ANTIBODIES FOR RADIOIMMUNOTHERAPY

    Amount: $500,000.00

    THE OBJECTIVE OF THIS PHASE I SBIR PROJECT IS TO DEVELOP A RE-186 AGENT SUITABLE FOR LABELING BIFUNCTIONAL CHELATING AGENT ANTIBODY CONJUGATES. ALTHOUGH CHEMICALLY SIMILAR TO TC-99M, APPLICATION OF RE ...

    SBIR Phase II 1986 Department of Health and Human Services
  4. THE PURPOSE OF THIS PROJECT IS TO LABEL MONOCLONAL ANTIBODIES WITH ASTATINE-211 FOR USE IN RADIO-IMMUNOTHERAPY.

    Amount: $50,000.00

    THE PURPOSE OF THIS PROJECT IS TO LABEL MONOCLONAL ANTIBODIES WITH ASTATINE-211 FOR USE IN RADIO-IMMUNOTHERAPY.THE GOAL OF THE PROPOSED RESEARCH IS TO DEVELOP A METHOD TO INCORPORATE ASTATINE INTO ANT ...

    SBIR Phase I 1986 Department of Health and Human Services
  5. THE OBJECTIVE OF THIS PHASE I PROJECT IS TO DEVELOP AND EVALUATE A NOVEL METHOD FOR RADIOLABELING MONOCLONAL ANTI- BODIES WITH TECHNETIUM-99M FOR THE SPECIFIC DIAGNOSIS OF CANCER.

    Amount: $50,000.00

    THE OBJECTIVE OF THIS PHASE I PROJECT IS TO DEVELOP AND EVALUATE A NOVEL METHOD FOR RADIOLABELING MONOCLONAL ANTI- BODIES WITH TECHNETIUM-99M FOR THE SPECIFIC DIAGNOSIS OF CANCER. THE METHOD PROVIDES ...

    SBIR Phase I 1986 Department of Health and Human Services
  6. RHENIUM-188 HAS FAVORABLE PHYSICAL PROPERTIES AS A THERA- PEUTIC RADIONUCLIDE, T-1/2 OF 17.

    Amount: $50,000.00

    RHENIUM-188 HAS FAVORABLE PHYSICAL PROPERTIES AS A THERA- PEUTIC RADIONUCLIDE, T-1/2 OF 17.0 HOURS, EMAX BETA 2.2 MEV,AND EGAMMA 155 KEV. METHODOLOGY HAS BEEN DEVELOPED FOR CONJUGATION OF RHENIUM IN S ...

    SBIR Phase I 1986 Department of Health and Human Services
  7. CONJUGATION OF SMALL RIBOSOMAL INHIBITORS TO ANTIBODIES

    Amount: $50,000.00

    NEORX CORPORATION PROPOSES A NEW SERIES OF SMALL-MOLECULAR WEIGHT NATURAL PRODUCTS THAT ARE SIMILAR TO HIGHER PLANT TOXINS IN THEIR MECHANISMS OF ACTION-INHIBITING PROTEIN SYNTHESIS AT THE LEVEL OF TH ...

    SBIR Phase I 1987 Department of Health and Human Services
  8. N/A

    Amount: $104,167.00

    N/A

    SBIR Phase II 2000 Department of Health and Human Services
  9. N/A

    Amount: $100,000.00

    N/A

    STTR Phase I 2000 Department of Health and Human Services
  10. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government